Adial Pharmaceuticals News

10-Q: Quarterly report

May 14 17:05 ET

8-K: Current report

Apr 26 16:06 ET

424B3: Prospectus

Apr 23 16:06 ET

EFFECT: Others

Apr 22 06:06 ET

424B5: Prospectus

Apr 18 17:33 ET

8-K: Current report

Apr 18 17:32 ET

8-K: Current report

Apr 16 16:42 ET

Adial Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Apr 12 16:28 ET

Adial Pharmaceuticals | 10-K: Annual report

Apr 1 16:03 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

Mar 27 18:25 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Newman James W. Jr.

Mar 27 18:25 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truluck Joseph

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Claiborne Cary J

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Anderson J. Kermit

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

Mar 27 18:10 ET

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Tony

Mar 27 18:10 ET

Adial Pharmaceuticals | D: Filing D

Mar 14 17:16 ET

Adial Pharmaceuticals | 8-K: Current report

Mar 6 16:29 ET

Adial Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 15:25 ET

Adial Pharmaceuticals | 424B5: Prospectus

Jan 25 16:35 ET